Reaginic antibodies to DNP and ovalbumin were induced readily in B6D2F1 mice by a single intraperitoneal injection of 1 µg of DNP-ovalbumin suspended with 1 mg aluminum hydroxide in 0.5 ml of saline. The formation of anti-DNP reaginic antibody was completely suppressed by treatment of mice with a conjugate consisting of the hapten coupled to an isologous, nonimmunogenic carrier, viz., murine γ-globulins. However, this treatment did not affect the level of antibody formation to the carrier of the immunizing antigen. The induction of unresponsiveness was dose dependent, complete suppression being achieved with 1 mg of the tolerogen. The state of unresponsiveness could be maintained for prolonged periods (these observations were made over a period of at least 8 months) by repeated injections of the tolerogen at intervals of 2 months. More importantly, the state of unresponsiveness could be induced readily not only in normal, but also in sensitized mice, i.e., this treatment was capable of abrogating an ongoing reaginic response, and the suppression was immunologically specific. Hence this system appears to have a great potential for adaptation to the treatment of allergic diseases in man.

1

This investigation was supported by grants from the Medical Research Council of Canada. The results of this study were presented at the 10th Symposium of the Collegium Internationale Allergologicum, Copenhagen, Denmark, August, 1974.

This content is only available via PDF.